Cardiovascular diseases (CVDs) remain the leading cause of health problems worldwide.
Nanotechnology, based on its unique properties, provides novel solutions to the diagnosis …

Carbohydrates are a class of macromolecules that has significant potential across several
domains, including the organisation of genetic material, provision of structural support, and …

The leading cause of heart disease in developed countries is coronary atherosclerosis,
which is not simply a result of ageing but a chronic inflammatory process that can lead to …

A complex metabolic condition referred to as Type 2 diabetes mellitus (T2DM) is
characterized by insulin resistance (IR) and decreased insulin production. Obesity …

Enzyme therapies are attracting significant attention as thrombolytic drugs during the current
scenario owing to their great affinity, specificity, catalytic activity, and stability. Among various …

Hydrogels and extracellular vesicle-based therapies have been proposed as emerging
therapeutic assets in wound closure. The combination of these elements has given good …

Thrombosis remains a leading cause of death worldwide despite technological advances in
prevention, diagnosis, and treatment. The traditional view of arterial thrombus formation is …

Current antithrombotic therapies used in clinical settings target either the coagulation
pathways or platelet activation receptors (P2Y12 or GPIIb/IIIa), as well as the …

Fucoidan is a marine polysaccharide. In recent years, fucoidan has attracted wide-scale
attention from the pharmaceutical industries due to its diverse biological activities such as …

Anticoagulants are the mainstay for the prevention and treatment of thrombosis. However,
bleeding complications remain a primary concern. Recent advances in understanding the …